Location History:
- San Francisco, CA (US) (2018)
- Oakland, CA (US) (2022)
Company Filing History:
Years Active: 2018-2022
Title: **Innovations of Martin Kampmann: Pioneering Genetic Research in Oakland, CA**
Introduction
Martin Kampmann is a notable inventor based in Oakland, California, recognized for his significant contributions to the field of genetic research. With two patents to his name, Kampmann is pushing the boundaries of genetic manipulation and its potential therapeutic applications.
Latest Patents
Kampmann's latest patents focus on advanced methodologies surrounding CRISPR technology. The first patent, titled "CRISPR/Cas transcriptional modulation," encompasses methods, compositions, and kits aimed at facilitating CRISPR/Cas mediated transcriptional modulation. This innovation is poised to enhance genome editing capabilities effectively.
The second patent details "Methods for genome-wide screening and construction of genetic interaction maps." This inventive approach provides methods to conduct screens using nucleic acid elements, including interfering RNAs, to accurately identify genetic elements of interest. The invention includes the development of vectors that incorporate multiple nucleic acid elements, allowing researchers to analyze interactions between gene pairs comprehensively. By quantifying the phenotypes of single and double-knockdown experiments, this patent lays the groundwork for creating genetic interaction maps. These maps can be instrumental in predicting functional associations among genes and identifying potential drug targets for combination cancer therapies.
Career Highlights
Martin Kampmann is affiliated with the University of California, where he actively contributes to groundbreaking research and innovation. His career has been marked by a commitment to advancing the understanding of genetic mechanisms and their application in medical science.
Collaborations
Kampmann collaborates with prominent figures in the field, including Jonathan S. Weissman and Luke A. Gilbert. These partnerships enhance the scope of his research and foster an environment of innovation and scientific discovery.
Conclusion
Martin Kampmann stands as a prominent inventor whose work in CRISPR technology and genetic research continues to shape the future of biomedical science. His patents not only reflect his innovative spirit but also hold the promise of significant advancements in understanding genetic interactions and developing therapeutic strategies. As he works at the University of California, the impact of his inventions will undoubtedly resonate across the scientific community and beyond.